Volume 22, Issue 2 - Medical Writing Around the World

Medical writing in the Russian Federation: Promises and pitfalls

Author: Anna Davydova

Abstract

Download the full article

References

1. Russia, The registry of Approved Clinical Trials [Реестр выданных разрешений на проведение клинических исследований лекарственных препаратов] [homepage on the Internet]. c2011 [cited 2013 February 16]. Available from: http://grls.rosminzdrav.ru/CIPermitionReg.aspx
2. Russia, National Standard of the Russian Federation. GOST R 52379-2005 ‘Good Clinical Practice’ [ГОСТ Р 52379-2005 ‘Качественна клиническая практика’]. c2005 [cited 2013 March 14]. Available from: State Law Publisher.
3. Russia, Federal Law #61 on Circulation of Medicines [Федеральный закон от 12.04.2010 года № 61-ФЗ ‘Об обращении лекарственных средств’] c2010 April 12 [cited 2013 March 14]. Available from: State Law Publisher.
4. Russia, Operating Instructions ‘Execution of Good Bioequivalence Studies of Drugs’ [Методические указания «Оценка биоэквивалентности лекарственных средств»], c2008 [cited 2013 March 14]. Available from: State Law Publisher.
5. World Health Organization. Multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability. c2005 [cited 2013 March 14]. Available from: http://www.who.int/medicines/services/expertcommittees/pharmprep/QAS04_093Rev4_final.pdf
6. Health Canada. Comparative bioavailability standards: formulations used for systemic effects. Available from: http://www.learnandconfirm.ca/resources/gd_standards_ld_normes-eng.pdf
7. . OCT attending and presenting at the Adam Smith Conference in Moscow [homepage on the Internet]. c2012 [cited 2013 March 14]. Available from: http://www.oct-clinicalstudies.com/?q=content/oct-attending-and-presenting-adam-smith-conference-moscow